Testing effectiveness (Phase 2)UnknownNCT05380492
What this trial is testing
Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
Who this might be right for
Age-related Macular DegenerationGeographic Atrophy
Perceive Biotherapeutics, Inc. 45